Cleared Traditional

MAGNETIC POINT GUARD FOR SURGICAL NEEDLES (K920706) - FDA 510(k) Clearance

Class I Gastroenterology & Urology device.

K920706 · Retrax · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1993
Decision
463d
Days
Class 1
Risk

K920706 is an FDA 510(k) clearance for the MAGNETIC POINT GUARD FOR SURGICAL NEEDLES. Classified as Holder, Needle, Gastroenterologic (product code FHQ), Class I - General Controls.

Submitted by Retrax (Wausau, US). The FDA issued a Cleared decision on May 26, 1993 after a review of 463 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4730 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Retrax devices

Submission Details

510(k) Number K920706 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 1992
Decision Date May 26, 1993
Days to Decision 463 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
333d slower than avg
Panel avg: 130d · This submission: 463d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code FHQ Holder, Needle, Gastroenterologic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 876.4730
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.